Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis : An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Thumbnail Image
4.-_SurvivalinaReal-WorldCohortofPatients.pdf (437.84 KB)
Identifiers
URI: https://hdl.handle.net/10641/7079
ISSN: 1071-9164
DOI: 10.1016/j.cardfail.2024.06.003

Publication date

2025-03

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Publisher Copyright: © 2024 The Authors

Keywords

Transthyretin amyloid cardiomyopathy, real-world, survival, tafamidis, Cardiology and Cardiovascular Medicine, SDG 3 - Good Health and Well-being, Journal Article, Yes, yes

Citation

THAOS Investigators 2025, 'Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis : An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)', Journal of Cardiac Failure, vol. 31, no. 3, pp. 525-533. https://doi.org/10.1016/j.cardfail.2024.06.003

Collections

FACULTAD DE MEDICINA